 |
Corporate News
26-Feb-25
|
|
|
|
|
|
|
|
|
|
|
|
Gland Pharma allots 4,700 equity shares under ESOP
|
|
|
|
|
|
|
|
Gland Pharma has allotted 4,700 equity shares under ESOP on 26 February 2025. Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs. 164,756,423/- comprising 164,756,423 equity shares of face value Re.1/- each.
|
|
|
|
Previous News |
Nifty trades above 24,550 mark; realty shares declined
(
Market Commentary
-
Mid-Session
04-Jun-25
10:36
)
|
|
|
Gland Pharma consolidated net profit declines 17.28% in the December 2023 quarter
(
Results
-
Announcements
14-Feb-24
17:22
)
|
|
|
Gland Pharma Ltd spurts 4.72%, gains for third straight session
(
Hot Pursuit
-
07-Nov-23
13:05
)
|
|
|
Gland Pharma to table results
(
Corporate News
-
09-May-24
14:47
)
|
|
|
Gland Pharma receives USFDA tentative approval for Latanoprostene Bunod Ophthalmic Solution
(
Corporate News
-
24-Jul-24
10:09
)
|
|
|
Gland Pharma appoints Srinivas Sadu as Executive Chairman and CEO
(
Corporate News
-
08-Jun-24
12:56
)
|
|
|
Gland Pharma consolidated net profit declines 72.48% in the March 2023 quarter
(
Results
-
Announcements
19-May-23
07:25
)
|
|
|
Gland Pharma Ltd spurts 0.04%, gains for fifth straight session
(
Hot Pursuit
-
17-Oct-22
13:01
)
|
|
|
Gland Pharma Ltd slips for fifth straight session
(
Hot Pursuit
-
23-Feb-24
13:35
)
|
|
|
Gland Pharma to hold board meeting
(
Corporate News
-
05-Apr-22
12:12
)
|
|
|
Gland Pharma Ltd Spurts 10.14%
(
Hot Pursuit
-
08-Aug-23
09:30
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|